Page results
-
Our vascular service has a major emphasis on endovascular (minimally invasive) treatments for vascular diseases, and this approach has largely replaced conventional open vascular surgery at UCLH.
-
The department offers a wide range of investigations and treatment for benign and cancerous surgical diseases, with specialisation in lower and upper GI surgery (including for weight loss).
-
This information provides information for women who have chosen to have surgical management using local anaesthetic following their diagnosis of a miscarriage.
-
This page provides general information about care of wounds following spinal surgery.
-
Visitors and staff enjoying the special performance at UCLH. The five poets and musician pictured: Madelaine Accalia, Esme Allman, Sarah McCreadie, Courtney Conrad, Thembe Mvula and Konstantinos Glynos (photo by: Alicia Clarke).
-
Many of our consultants in infectious and tropical diseases hold the only dedicated NHS positions in their respective fields, including parasitology, leprosy, leishmaniasis, and tropical dermatology.
-
Information on exercise following your urogynaecological surgery
-
Coping with nausea patient information page.
-
Professor Lunn's specialist clinical and research interests are in the inflammatory neuropathies, particularly Guillain-Barré syndrome, CIDP and paraproteinaemic neuropathies.
-
UCLH is the only Supra-Centre in England to deliver Intracranial Stereotactic Radiosurgery and Stereotactic Radiotherapy Services (SRS/SRT) as part of an integrated neurosurgical and Neuro-oncology service to patients.
File results
-
FOI/2024/0155 - Immunotherapy treatments for lung cancer
-
FOI/2024/0162 - Various technology systems/ services used at Trust
-
FOI/2024/0163 - Renal cell carcinoma and melanoma treatments
-
FOI/2024/0166 - Recruitment systems/CRM platform
-
FOI/2024/0171 - Dermatology consultants
-
FOI/2024/0172 - Patients excluded from care at the Trust 2010-2023
-
FOI/2024/0179 - Water usage/ procurement
-
FOI/2024/0183 - Immunology Hidradenitis Suppurativa (HS) treatment
-
FOI/2024/0184 - IT spend/ Healthcare Information and Management Systems Society (HIMSS) EMRAM and INFRAM scores
-
FOI/2024/0190 - Scheduled appointments Did Not Attend (DNA) 2019-2023